共 45 条
- [31] A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG1 Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid MalignanciesCLINICAL CANCER RESEARCH, 2010, 16 (06) : 1915 - 1923Kuenen, BartWitteveen, Petronella O.Ruijter, RitaGiaccone, GiuseppeDontabhaktuni, ArunaFox, FloydKatz, TerryYoussoufian, HagopZhu, JunmingRowinsky, Eric K.Voest, Emile E.
- [32] EFFECTS OF RG7652, A FULLY HUMAN MAB AGAINST PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, ON LDL-C: A PHASE I, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE- AND MULTIPLE-DOSE STUDYHEART, 2013, 99 : E153 - E153Tingley, WhittemoreLuca, DianaLeabman, MayaBudha, NageshwarKahn, RobertBaruch, AmosCowan, KyraDavis, John C.
- [33] Effects of RG7652, a fully human mAb against proprotein convertase subtilisin/kexin type 9, on LDL-c: a Phase I, randomised, double-blind, placebo-controlled, single- and multiple-dose studyEUROPEAN HEART JOURNAL, 2013, 34 : 767 - 767Tingley, W.Luca, D.Leabman, M.Budha, N.Kahn, R.Baruch, A.Cowan, K.Davis, J. C.
- [34] A phase I. first-in-human study of ARGX-110, a monoclonal antibody targeting CD70, a receptor involved in immune escape and tumor growth in patients with solid and hematologic malignancies.JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)Awada, AhmadRolfo, Christian D.Rottey, Sylviade Lendonck, Laure YsebrantSchroyens, Wilfrled A.Offner, FritzSilence, KarenDreier, TorstenMoshir, Mahande Heard, HansPosters, MarcBron, DominiqueThibault, AlainAftimos, Philippe G.
- [35] Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) : 780 - 787Spratlin, Jennifer L.Cohen, Roger B.Eadens, MatthewGore, LiaCamidge, D. RossDiab, SamiLeong, StephenO'Bryant, CindyChow, Laura Q. M.Serkova, Natalie J.Meropol, Neal J.Lewis, Nancy L.Chiorean, E. GabrielaFox, FloydYoussoufian, HagopRowinsky, Eric K.Eckhardt, S. Gail
- [36] Phase I study of BC001, a novel fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2, in advanced solid tumorsCANCER MEDICINE, 2024, 13 (22):Liu, DanGong, JifangLiu, MulingZhou, HuanWang, ShumeiYang, JianShang, ChenweiGuo, XinleiWang, ChaZhang, YanqiaoShen, Lin
- [37] Phase I study of a fully human monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand death receptor 4 (TRAIL-R1) in subjects with advanced solid malignancies or non-Hodgkin's lymphoma (NHL)JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 171S - 171SLe, LHHirte, HWHotte, SJMaclean, MIacobucci, ACorey, AFox, NLOza, AM
- [38] Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kinases, in Japanese patients with advanced solid tumorsInvestigational New Drugs, 2012, 30 : 2352 - 2363Toshiaki TakahashiNarikazu BokuHaruyasu MurakamiTateaki NaitoAsuka TsuyaYukiko NakamuraAkira OnoNozomu MachidaKentaro YamazakiJunichiro WatanabeAna Ruiz-GarciaKeiji ImaiEmiko OhkiNobuyuki Yamamoto
- [39] Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1,-2, and -4 tyrosine kinases, in Japanese patients with advanced solid tumorsINVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2352 - 2363Takahashi, ToshiakiBoku, NarikazuMurakami, HaruyasuNaito, TateakiTsuya, AsukaNakamura, YukikoOno, AkiraMachida, NozomuYamazaki, KentaroWatanabe, JunichiroRuiz-Garcia, AnaImai, KeijiOhki, EmikoYamamoto, Nobuyuki
- [40] A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG1 Monoclonal Antibody Directed against EGFR in Patients with Advanced Solid Malignancies (vol 16, pg 1915, 2010)CLINICAL CANCER RESEARCH, 2010, 16 (18) : 4681 - 4681Kuenen, B.Witteveen, P. O.Ruijter, R.Giaccone, G.Dontabhaktuni, A.Fox, F.Katz, T.Youssoufian, H.Zhu, J.Rowinsky, E. K.Voest, E. E.